Bluebird Historical Financial Ratios
| BLUE Stock | USD 0.39 0.03 7.14% |
Bluebird Bio is presently reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.46 or Days Sales Outstanding of 153 will help investors to properly organize and evaluate Bluebird bio financial condition quickly.
Bluebird |
About Bluebird Financial Ratios Analysis
Bluebird bioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bluebird Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bluebird financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bluebird Bio history.
Bluebird Bio Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Bluebird bio stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bluebird Bio sales, a figure that is much harder to manipulate than other Bluebird bio multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Bluebird Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bluebird bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.At present, Bluebird Bio's Days Of Inventory On Hand is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 6.41, whereas PTB Ratio is forecasted to decline to 0.46.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 31.59 | 13.81 | 8.77 | 8.33 | Receivables Turnover | 0.32 | 0.33 | 2.27 | 2.15 |
Bluebird Bio fundamentals Correlations
Click cells to compare fundamentals
Bluebird Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bluebird Bio fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 70.21 | 6.95 | 187.99 | 151.18 | 5.14 | 4.88 | |
| Ptb Ratio | 2.44 | 1.29 | 1.84 | 2.77 | 0.78 | 0.46 | |
| Book Value Per Share | 23.28 | 21.79 | 5.43 | 2.5 | 1.77 | 1.68 | |
| Free Cash Flow Yield | (0.2) | (0.29) | (0.96) | (0.67) | (1.61) | (1.53) | |
| Operating Cash Flow Per Share | (7.95) | (10.23) | (7.56) | (9.22) | (4.49) | (2.14) | |
| Stock Based Compensation To Revenue | 3.6 | 0.62 | 34.93 | 9.78 | 0.66 | 0.63 | |
| Capex To Depreciation | 4.37 | 1.5 | 1.17 | 2.64 | 0.32 | 0.3 | |
| Pb Ratio | 2.44 | 1.29 | 1.84 | 2.77 | 0.78 | 0.46 | |
| Ev To Sales | 67.16 | 6.45 | 168.44 | 198.0 | 8.82 | 8.38 | |
| Free Cash Flow Per Share | (11.61) | (8.03) | (9.56) | (4.66) | (2.22) | (2.33) | |
| Roic | (0.62) | (0.47) | (1.49) | (1.46) | (1.25) | (1.19) | |
| Inventory Turnover | (0.0206) | (0.036) | (0.36) | (7.13) | 1.46 | 1.54 | |
| Net Income Per Share | (14.31) | (9.95) | (8.16) | (3.39) | (1.93) | (2.03) | |
| Days Of Inventory On Hand | (17.7K) | (10.1K) | (1.0K) | (51.22) | 249.51 | 261.99 | |
| Payables Turnover | 0.0693 | 0.39 | 1.5 | 0.68 | 1.81 | 1.72 | |
| Research And Ddevelopement To Revenue | 13.04 | 2.34 | 87.37 | 66.93 | 5.68 | 5.4 | |
| Capex To Revenue | 1.71 | 0.12 | 6.28 | 3.67 | 0.31 | 0.29 | |
| Cash Per Share | 20.05 | 18.52 | 4.35 | 2.29 | 2.02 | 1.92 | |
| Pocfratio | (5.56) | (3.7) | (1.08) | (1.54) | (0.64) | (0.68) | |
| Capex To Operating Cash Flow | (0.14) | (0.0616) | (0.0362) | (0.0374) | (0.0385) | (0.0405) | |
| Pfcf Ratio | (4.9) | (3.49) | (1.05) | (1.49) | (0.62) | (0.65) | |
| Days Payables Outstanding | 5.3K | 934.21 | 243.13 | 538.5 | 201.38 | 191.31 | |
| Income Quality | 0.74 | 0.71 | 0.76 | 1.32 | 1.11 | 1.16 | |
| Roe | (0.61) | (0.46) | (1.5) | (1.36) | (1.09) | (1.03) | |
| Ev To Operating Cash Flow | (5.32) | (3.44) | (0.97) | (2.02) | (1.11) | (1.16) | |
| Pe Ratio | (3.97) | (2.82) | (1.22) | (2.04) | (0.72) | (0.75) | |
| Return On Tangible Assets | (0.25) | (0.46) | (0.35) | (0.96) | (0.49) | (0.37) | |
| Ev To Free Cash Flow | (4.68) | (3.24) | (0.94) | (1.95) | (1.07) | (1.12) | |
| Earnings Yield | (0.25) | (0.36) | (0.82) | (0.49) | (1.4) | (1.33) | |
| Intangibles To Total Assets | 0.0159 | 0.013 | 0.009508 | 0.0189 | 0.026 | 0.0278 | |
| Net Debt To E B I T D A | 0.18 | 0.23 | 0.13 | (0.78) | (0.65) | (0.62) | |
| Current Ratio | 5.15 | 5.97 | 2.2 | 1.56 | 1.41 | 1.34 | |
| Tangible Book Value Per Share | 22.79 | 21.42 | 5.35 | 2.36 | 1.62 | 1.54 | |
| Graham Number | 86.57 | 69.85 | 31.59 | 13.81 | 8.77 | 8.33 | |
| Shareholders Equity Per Share | 23.28 | 21.79 | 5.43 | 2.5 | 1.77 | 1.68 | |
| Capex Per Share | 1.07 | 1.38 | 0.47 | 0.17 | 0.0825 | 0.0783 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.80) | Revenue Per Share 0.357 | Quarterly Revenue Growth 1.337 | Return On Assets (0.36) | Return On Equity (1.87) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.